The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessAbstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Müllner, M., Urbanek, B., Havel, C., Losert, H., Gamper, G., & Herkner, H. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub2 · Cited by 654
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
The Design and Analysis of Sequential Clinical Trials.
Harrington, D., & Whitehead, J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288093 · Cited by 634
Annane, D., Vignon, P., Renault, A., Bollaert, P.-E., Charpentier, C., Martin, C., Troché, G., Ricard, J.-D., Nitenberg, G., Papazian, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61344-0 · Cited by 567
Hemodynamic variables related to outcome in septic shock
Varpula, M., Tallgren, M., Saukkonen, K., Voipio-Pulkki, L.-M., & Pettilä, V. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2688-z · Cited by 555
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
Blanco, J., Muriel-Bombín, A., Sagredo, V., Taboada, F., Gandía, F., Tamayo, L., Collado, J., García-Labattut, Á., Carriedo, D., Valledor, M., et al. (2008) · Critical Care · doi:10.1186/cc7157 · Cited by 520
Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
(1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00049 · Cited by 438
Sakr, Y., Reinhart, K., Vincent, J.-L., Sprung, C. L., Moreno, R., Ranieri, V. M., De Backer, D., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201896.45809.e3 · Cited by 404
Self-citationMarik, P. E. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520170064037 · Cited by 401
De Backer, D., Creteur, J., Silva, E., & Vincent, J.-L. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063045.77339.b6 · Cited by 371
Self-citationEffect of norepinephrine on the outcome of septic shock
Martin, C., Viviand, X., Leone, M., & Thirion, X. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00012 · Cited by 366
Vasopressor and inotropic support in septic shock: An evidence-based review
Beale, R. J., Hollenberg, S. M., Vincent, J.-L., & Parrillo, J. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142909.86238.b1 · Cited by 260
Self-citationAnterior pituitary function during critical illness and dopamine treatment
Van den Berghe, G., & de Zegher, F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00024 · Cited by 256
Hemodynamic studies and results of therapy in 50 patients with bacteremic shock
Winslow, E. J., Loeb, H. S., Rahimtoola, S. H., Kamath, S., & Gunnar, R. M. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90038-7 · Cited by 246
Acute Hemodynamic Effects of Dopamine in Patients with Shock
LOEB, H. S., WINSLOW, E. B. J., RAHIMTOOLA, S. H., ROSEN, K. M., & GUNNAR, R. M. (1971) · Circulation · doi:10.1161/01.cir.44.2.163 · Cited by 167
The significance of non-sustained hypotension in emergency department patients with sepsis
Marchick, M. R., Kline, J. A., & Jones, A. E. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1448-x · Cited by 86
Marik, P. E. (1994) · JAMA · doi:10.1001/jama.272.17.1354 · Cited by 76
Póvoa, P. M. S. R., Carneiro, A., Ribeiro, O., & Costa‐Pereira, A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181958b1c · Cited by 73
Lévy, B., Dusang, B., Annane, D., Gibot, S., & Bollaert, P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181297.14319.3c · Cited by 60
The Dopamine Paradox in Lung and Kidney Epithelia
Bertorello, A. M., & Sznajder, J. I. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0297tr · Cited by 60
Ungar, A., Fumagalli, S., Marini, M., Serio, C. D., Tarantini, F., Boncinelli, L., Baldereschi, G. J., Valoti, P., Cava, G. L., Olianti, C., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000124871.58281.d1 · Cited by 57
Dopamine therapy in septic shock: Detrimental effect on survival?
Boulain, T., Runge, I., Bercault, N., Benzékri-Lefèvre, D., Wolf, M., & Fleury, C. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.11.003 · Cited by 22
Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit
Davenport, A. (2008) · Critical Care · doi:10.1186/cc6914 · Cited by 10
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citation
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.